Voyager Therapeutics (VYGR) FCF Margin Growth (5y) (2020 - 2026)
Voyager Therapeutics (VYGR) FCF Margin Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95,604.00 |
| Dec 31, 2025 | 14,834.00 |
| Sep 30, 2025 | -21,292.00 |
| Jun 30, 2025 | -58,721.00 |
| Mar 31, 2025 | -43,658.00 |
| Dec 31, 2024 | -13,919.00 |
| Sep 30, 2024 | -706.00 |
| Jun 30, 2024 | -4,874.00 |
| Mar 31, 2024 | -210,689.00 |
| Dec 31, 2023 | 139,077.00 |
| Sep 30, 2023 | 33,342.00 |
| Jun 30, 2023 | 87,217.00 |
| Mar 31, 2023 | -507,587.00 |
| Dec 31, 2022 | 108,642.00 |
| Sep 30, 2022 | 166,575.00 |
| Jun 30, 2022 | -143,435.00 |
| Mar 31, 2022 | 637,479.00 |
| Dec 31, 2021 | 75,743.00 |
| Sep 30, 2021 | -100,729.00 |
| Jun 30, 2021 | -144,356.00 |